The securities of BARD1 Life Sciences Limited (‘BD1’) will be placed in trading halt at the request of BD1, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Friday, 23 July 2021 or when the announcement is released to the market.
For more information, download the attached PDF.
Download this document
